MolPort-001-759-083

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

56 Suppliers, 36 USDMF, 10 EU WC, 8 KDMF, 31 NDC API, 31 Listed Suppliers

DEVELOPMENTS

27 Drug(s) in Development

27 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

246 Dossiers, 130 FDA Orange Book, 76 Europe, 12 Canada, 2 Australia, 13 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 35 BASF, 21 Microlex e.U, 19 Roquette, 19 SPI Pharma, 16 Corel Pharma Chem, 15 Ideal Cures Pvt Ltd, 14 Seppic, 12 Gangwal Chemicals, 10 Nanjing Well Pharmaceutical, 10 Sigachi Industries, 10 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Actylis, 6 Lonza Capsugel, 5 DFE Pharma, 5 Kima Chemical, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 The Dow Chemical Company, 4 DKSH, 4 Alcedo Pharmachem, 3 Finar, 3 Prachin Chemical, 3 Doshion Polyscience, 3 Pharmatrans-Sanaq, 3 Ingredion Pharma Solutions, 2 Nomisma Healthcare, 2 Seqens, 2 Vertellus, 2 Vasa Pharmachem, 2 Jai Radhe Sales, 2 Clariant, 2 Evonik, 2 Boai NKY Pharmaceuticals Ltd, 2 Rochem International Inc, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 Minakem, 1 Ulanqab Kema New Material, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 77 Coating Systems & Additives, 51 Controlled & Modified Release, 43 Direct Compression, 34 Solubilizers, 29 Lubricants & Glidants, 29 Granulation, 27 Film Formers & Plasticizers, 27 Thickeners and Stabilizers, 26 Taste Masking, 23 Parenteral, 22 Topical, 18 Disintegrants & Superdisintegrants, 17 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 9 Emulsifying Agents, 8 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

64 US Medicaid Prescriptions, 53 Finished Drug Prices

MARKET PLACE

10 APIs, 2 DOSSIERS // FDF, 1 CONTRACT SERVICES

PATENTS

21 US Patents, 30 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 5 USP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 90 News

Information, Expiry & Status of Health Canada Patents covering MolPort-001-759-083.

MolPort-001-759-083

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

56 Suppliers

36 USDMF

10 EU WC

8 KDMF

31 NDC API

31 Listed Suppliers

DEVELOPMENTS

27 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

246 Dossiers

130 FDA Orange Book

76 Europe

12 Canada

2 Australia

13 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

TABLET, EXTENDED RELEASE;ORAL - 100MG

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 200MG

TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

35 BASF

21 Microlex e.U

19 Roquette

19 SPI Pharma

16 Corel Pharma Chem

15 Ideal Cures Pvt Ltd

14 Seppic

12 Gangwal Chemicals

10 Nanjing Well Pharmaceutical

10 Sigachi Industries

10 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Actylis

6 Lonza Capsugel

5 DFE Pharma

5 Kima Chemical

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 The Dow Chemical Company

4 DKSH

4 Alcedo Pharmachem

3 Finar

3 Prachin Chemical

3 Doshion Polyscience

3 Pharmatrans-Sanaq

3 Ingredion Pharma Solutions

2 Nomisma Healthcare

2 Seqens

2 Vertellus

2 Vasa Pharmachem

2 Jai Radhe Sales

2 Clariant

2 Evonik

2 Boai NKY Pharmaceuticals Ltd

2 Rochem International Inc

1 Pfanstiehl

1 Nanjing Bold Chemical

1 Minakem

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons